Synthego Corporation Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • Synthego Corporation's estimated annual revenue is currently $112.2M per year.(i)
  • Synthego Corporation received $110.0M in venture funding in October 2018.
  • Synthego Corporation's estimated revenue per employee is $217,000
  • Synthego Corporation's total funding is $459.7M.

Employee Data

  • Synthego Corporation has 517 Employees.(i)
  • Synthego Corporation grew their employee count by 44% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego's vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist. Headquartered in Silicon Valley, California, Synthego customers include leading institutions in 31 countries around the world, and 9 of the top 10 global biology universities.

keywords:saas, Biotechnology,Hardware,Healthcare,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Synthego Corporation News

2022-04-17 - Synthetic Biology Market Size And Forecast | Cyrus Biotechnology ...

(U.S.), Synthego Corporation (U.S.) among others. The report provides a good overview of the key macroeconomic factors that have a significant...

2022-04-13 - Europe CRISPR Gene Editing Market to 2031 - Featuring Abcam ...

Synthego Corporation; System Biosciences LLC; Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. For more information about this...

2022-02-22 - Synthego Raises $200 Million to Accelerate the Field of CRISPR ...

Synthego was founded to revolutionize genome engineering technology, helping translate genomics into the clinic and ultimately making engineered...

2020-08-27 - Synthego Raises $100M in Series D Funding

Synthego, a Redwood City, Calif.-based genome engineering company, raised $100m in Series D financing. The round was led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors included Founders Fund, Menlo Ventures, and Intel Capital. This new round ...

Synthego Corporation Funding

DateAmountRoundLead InvestorsReference
2017-10-23$UndisclosedUndisclosedIntel CapitalArticle
2018-10-24$110.0MCFounders FundArticle